Analysis Thyrocare Technologies Limited (THYROCARE)
6/2/2024
Analysis of Thyrocare Technologies Limited (THYROCARE)
Thyrocare Technologies Limited is showing some interesting trends based on the provided data:1. **Price Movement**: The closing prices have been fluctuating between 612.25 and 643.40 over the past few days, indicating some volatility in the stock.
2. **Relative Strength Index (RSI)**: The RSI values have been hovering around 40-50, suggesting that the stock is neither overbought nor oversold. This indicates a balanced market sentiment.
3. **Moving Average Convergence Divergence (MACD)**: The MACD line has been below the signal line, indicating a bearish trend. However, the MACD histogram has been fluctuating, suggesting some indecision in the market.
4. **Moving Averages (MA)**: The closing prices have been below the Moving Averages, indicating a potential bearish trend.
Overall, Thyrocare Technologies Limited seems to be experiencing some volatility with mixed signals from different indicators. Traders and investors may need to closely monitor the stock for clearer trends before making any decisions.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a projected growth rate of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, showing a 1% growth rate from the previous year. The number of analysts providing estimates has increased to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth rate of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly increasing number of analysts providing forecasts.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant increase in growth rate from the current and past performance, especially in the upcoming year and the next 5 years. The past 5 years have shown a much higher growth rate compared to the current estimates, indicating a potential change in the company's growth trajectory.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which falls below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a relatively low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and forward P/E ratio. The company's market capitalization and enterprise value are substantial, with a high price-to-book ratio and price-to-sales ratio.
The stock price summary includes beta, moving averages, and the range of prices over the past fifty-two weeks.
Lastly, dividends and splits information shows the company's dividend dates, payout ratio, and dividend yield metrics, along with details of past stock splits.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Earnings before interest and taxes (EBIT) have shown an upward trend, reaching $117.7 billion in 2023 from $69.9 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. The company has been able to maintain a healthy EBITDA margin over the years, indicating operational efficiency.
7. Diluted earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
8. The company's tax expenses have increased over the years, reflecting higher profitability.
9. Overall, the financial performance of the company seems to be improving, with a focus on revenue growth and cost management.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. The company has been investing in leases, land, and improvements over the years.
9. There is a consistent provision for risks and charges in the liabilities section.
10. Overall, the company's financial health seems stable and improving over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuances.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, but generally, the company has maintained a healthy cash balance.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been paying dividends consistently, with varying amounts each year.
9. The company has engaged in acquisitions and divestitures, impacting the investing cash flow.
10. Overall, the company's cash flow statement reflects a mix of stable and fluctuating financial activities, indicating a dynamic financial position.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. The EPS is expected to be higher than the $1.35 reported in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. Analysts are forecasting an increase in EPS compared to the $6.10 reported in the previous year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
MACD of THYROCARE
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
